CY1106020T1 - Χρηση αναλογων caba για την βιομηχανικη κατασκευη ενος φαρμακου για την θepαπεια μανιας και διπολικων διαταραχων - Google Patents
Χρηση αναλογων caba για την βιομηχανικη κατασκευη ενος φαρμακου για την θepαπεια μανιας και διπολικων διαταραχωνInfo
- Publication number
- CY1106020T1 CY1106020T1 CY20071100204T CY071100204T CY1106020T1 CY 1106020 T1 CY1106020 T1 CY 1106020T1 CY 20071100204 T CY20071100204 T CY 20071100204T CY 071100204 T CY071100204 T CY 071100204T CY 1106020 T1 CY1106020 T1 CY 1106020T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- mania
- caba
- analogues
- drug
- Prior art date
Links
- 208000020925 Bipolar disease Diseases 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 206010026749 Mania Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1
- 229960001233 pregabalin Drugs 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000000306 recurrent effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Abstract
Η παρούσα εφεύρεση είναι μία νέα θεραπευτική χρήση της pregabalin, παραγώγων αυτής και των φαρμακευτικών αλάτων αυτής. Οι ενώσεις είναι χρήσιμες στη θεραπεία μανίας, σε όλες τις διάφορες μορφές αυτής, ανεξάρτητα εάν είναι οξεία ή χρόνια, απλή ή υποτροπιάζουσα ή/και κατά πόσο ή όχι αυτή συνδυάζεται με κατάθλιψη. Η εφεύρεση περαιτέρω περιλαμβάνει προληπτική θεραπεία διπολικής διαταραχής.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10453598P | 1998-10-16 | 1998-10-16 | |
PCT/US1999/018981 WO2000023067A1 (en) | 1998-10-16 | 1999-08-18 | Method for the treatment of mania and bipolar disorder |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106020T1 true CY1106020T1 (el) | 2011-04-06 |
Family
ID=22300998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20071100204T CY1106020T1 (el) | 1998-10-16 | 2007-02-15 | Χρηση αναλογων caba για την βιομηχανικη κατασκευη ενος φαρμακου για την θepαπεια μανιας και διπολικων διαταραχων |
Country Status (16)
Country | Link |
---|---|
US (1) | US6359005B1 (el) |
EP (1) | EP1121114B1 (el) |
JP (1) | JP2002527474A (el) |
KR (1) | KR100697734B1 (el) |
AU (1) | AU762599B2 (el) |
CA (1) | CA2344407C (el) |
CY (1) | CY1106020T1 (el) |
DE (1) | DE69934813T2 (el) |
DK (1) | DK1121114T3 (el) |
ES (1) | ES2279631T3 (el) |
HU (1) | HUP0103842A3 (el) |
IL (1) | IL142225A (el) |
NZ (1) | NZ510920A (el) |
PT (1) | PT1121114E (el) |
WO (1) | WO2000023067A1 (el) |
ZA (1) | ZA200102561B (el) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1094757C (zh) | 1996-07-24 | 2002-11-27 | 沃尼尔·朗伯公司 | 用于治疗疼痛的异丁基γ-氨基丁酸及其衍生物 |
AU2002211863A1 (en) | 2000-10-06 | 2002-04-15 | Xenoport, Inc. | Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration |
AU2002230398A1 (en) | 2000-10-06 | 2002-04-29 | Xenoport, Inc. | Bile-acid conjugates for providing sustained systemic concentrations of drugs |
US7022678B2 (en) * | 2001-03-30 | 2006-04-04 | Warner-Lambert Company | Pregabalin lactose conjugates |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
WO2002100344A2 (en) | 2001-06-11 | 2002-12-19 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
MXPA03011566A (es) | 2001-06-11 | 2004-10-28 | Xenoport Inc | Formas de dosificacion de profarmacos de analogos de gaba administrados oralmente que tienen toxicidad reducida. |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US6927036B2 (en) | 2002-02-19 | 2005-08-09 | Xero Port, Inc. | Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
AU2003243180A1 (en) | 2002-05-17 | 2003-12-12 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
WO2004052360A1 (en) | 2002-12-11 | 2004-06-24 | Xenoport, Inc. | Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof |
EP1572187A1 (en) * | 2002-12-13 | 2005-09-14 | Warner-Lambert Company LLC | Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders |
BRPI0414481A (pt) | 2003-09-17 | 2006-11-14 | Xenoport Inc | métodos de tratamento ou de prevenção da sìndrome das pernas inquietas em um paciente e de melhoria do sono em um paciente com sìndrome das pernas inquietas, e, composição farmacêutica |
CA2541752C (en) | 2003-10-14 | 2012-01-03 | Xenoport, Inc. | Crystalline form of gamma-aminobutyric acid analog |
DE602005002253T2 (de) * | 2004-03-12 | 2008-05-29 | Warner-Lambert Company Llc | C1-symmetrische bisphosphinliganden und deren verwendung bei der asymmetrischen synthese von pregabalin |
ES2309731T3 (es) * | 2004-04-01 | 2008-12-16 | Warner-Lambert Company Llc | Preparacion de fosfolanos p-quirogenicos y su uso en sintesis asimetrica. |
CA2571040C (en) * | 2004-06-21 | 2009-09-15 | Warner-Lambert Company Llc | Preparation of pregabalin and related compounds |
NZ554737A (en) | 2004-11-04 | 2011-04-29 | Xenoport Inc | Gabapentin prodrug sustained release oral dosage forms |
EP2116618A1 (en) | 2008-05-09 | 2009-11-11 | Agency for Science, Technology And Research | Diagnosis and treatment of Kawasaki disease |
WO2011141923A2 (en) | 2010-05-14 | 2011-11-17 | Lupin Limited | Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin |
WO2012059797A1 (en) | 2010-11-04 | 2012-05-10 | Lupin Limited | Process for synthesis of (s) - pregabalin |
KR101035974B1 (ko) * | 2011-02-28 | 2011-05-23 | (주) 경화엔지니어링 | 하수, 폐수 및 침출수 관거용 탈취장치 |
EP3793974A4 (en) | 2018-05-14 | 2022-05-04 | Xgene Pharmaceutical Inc | CRYSTALLINE FORMS OF THE 1-(ACYLOXY)-ALKYL CARBAMATE DRUG CONJUGATE OF NAPROXEN AND PREGABALIN |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0641330B1 (en) * | 1992-05-20 | 2001-10-17 | Northwestern University | Gaba and l-glutamic acid analogs for antiseizure treatment |
US5510381A (en) * | 1995-05-15 | 1996-04-23 | Warner-Lambert Company | Method of treatment of mania and bipolar disorder |
BR9712651A (pt) * | 1996-10-23 | 1999-10-26 | Warner Lambert Co | cidos gama-aminobutìricos substituìdos com agentes farmacêuticos. |
US6194459B1 (en) * | 1997-08-19 | 2001-02-27 | Warner-Lambert Company | Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants |
-
1999
- 1999-08-18 PT PT99941238T patent/PT1121114E/pt unknown
- 1999-08-18 WO PCT/US1999/018981 patent/WO2000023067A1/en active IP Right Grant
- 1999-08-18 US US09/807,484 patent/US6359005B1/en not_active Expired - Fee Related
- 1999-08-18 JP JP2000576842A patent/JP2002527474A/ja active Pending
- 1999-08-18 CA CA002344407A patent/CA2344407C/en not_active Expired - Fee Related
- 1999-08-18 AU AU54930/99A patent/AU762599B2/en not_active Ceased
- 1999-08-18 ES ES99941238T patent/ES2279631T3/es not_active Expired - Lifetime
- 1999-08-18 NZ NZ510920A patent/NZ510920A/xx not_active IP Right Cessation
- 1999-08-18 DK DK99941238T patent/DK1121114T3/da active
- 1999-08-18 HU HU0103842A patent/HUP0103842A3/hu unknown
- 1999-08-18 EP EP99941238A patent/EP1121114B1/en not_active Expired - Lifetime
- 1999-08-18 DE DE69934813T patent/DE69934813T2/de not_active Expired - Lifetime
- 1999-08-18 KR KR1020017004730A patent/KR100697734B1/ko not_active IP Right Cessation
-
2001
- 2001-03-22 IL IL142225A patent/IL142225A/en not_active IP Right Cessation
- 2001-03-28 ZA ZA200102561A patent/ZA200102561B/en unknown
-
2007
- 2007-02-15 CY CY20071100204T patent/CY1106020T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69934813T2 (de) | 2007-10-11 |
HUP0103842A3 (en) | 2003-04-28 |
PT1121114E (pt) | 2007-03-30 |
AU5493099A (en) | 2000-05-08 |
HUP0103842A2 (hu) | 2002-02-28 |
ZA200102561B (en) | 2002-09-30 |
DE69934813D1 (de) | 2007-02-22 |
EP1121114B1 (en) | 2007-01-10 |
ES2279631T3 (es) | 2007-08-16 |
KR100697734B1 (ko) | 2007-03-22 |
CA2344407A1 (en) | 2000-04-27 |
US6359005B1 (en) | 2002-03-19 |
WO2000023067A1 (en) | 2000-04-27 |
EP1121114A1 (en) | 2001-08-08 |
AU762599B2 (en) | 2003-06-26 |
IL142225A (en) | 2009-09-22 |
JP2002527474A (ja) | 2002-08-27 |
NZ510920A (en) | 2002-08-28 |
CA2344407C (en) | 2007-01-09 |
KR20010080165A (ko) | 2001-08-22 |
DK1121114T3 (da) | 2007-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106020T1 (el) | Χρηση αναλογων caba για την βιομηχανικη κατασκευη ενος φαρμακου για την θepαπεια μανιας και διπολικων διαταραχων | |
UY25157A1 (es) | Composiciones farmacéuticas conteniendo atorvastatina y amlodipino | |
CY1110570T1 (el) | Χρηση της ουριδινης σε συνδυασμο με χολινη για τη θεραπεια διαταραχων της μνημης | |
CY1111504T1 (el) | Αζαδικυκλοαλκανια ως ρυθμιστες του ccr5 | |
SV1997000079A (es) | Dihidrato d de olancepina ref. x- 11062t | |
CY1109981T1 (el) | Αναλογα του gaba για την προληψη και αγωγη γαστρεντερικης βλαβης | |
CY1106992T1 (el) | Καχαλαλιδη f και συναφεις ενωσεις | |
CY1105501T1 (el) | Συνδυασμοι φαρμακων (π.χ. chlorpromazine και pentamidine) για την αντιμετωπιση νεοπλαστικων διαταραχων | |
CY1105653T1 (el) | Στεροειδεις σαπωνινες για τη θεραπεια της νοσου alzheimer | |
CY1110405T1 (el) | Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων | |
EE03420B1 (et) | Farmatseutiline kompositsioon maania ja bipolaarse häire raviks | |
ATE231872T1 (de) | Thiazolopyrimidinderivate | |
CY1112361T1 (el) | Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743 | |
DK1296671T3 (da) | Gabapentinanaloger til sövnforstyrrelser | |
CY1112962T1 (el) | 1,2-διαρυλο βενζιμιδαζολες για την αντιμετωπιση ασθενειων, οι οποιες σχετιζονται με την ενεργοποιηση μικρογλοιων | |
HUP0104709A2 (hu) | Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására | |
ES2173284T3 (es) | Agentes endoparasicitidas. | |
ES2193055T3 (es) | Cloruro de n- (2-hidroxi-3- (1-piperidinil) piridina-1-oxido-3-carboximidoilo y su uso en el tratamiento de la resistencia a la insulina. | |
HUP0002175A1 (hu) | Xa-faktor inhibitorok alkalmazása önmagában vagy vérlemezkeaggregáció-gátló szerrel kombinálva artéria trombózis megelőzésére és kezelésére | |
ES2056180T3 (es) | Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina. | |
CY1111509T1 (el) | Ενωσεις με ιδιοτητες απελευθερωσης αυξητικης ορμονης | |
BR9814419A (pt) | "combinação de compostos de benzociclo-heptapiridina e drogas antineopláticas para tratamento de doenças proliferativas" | |
ES2193065T3 (es) | Nueva utilizacion del saredutant. | |
ATE317849T1 (de) | 5-hydroxysapogenin derivate mit aktivität gegen demenz | |
BR9811643A (pt) | Suplementação quìmica de osso |